Loading clinical trials...
Loading clinical trials...
A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 versus NTCB-C in patients who require parenteral nutr...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Yuhan Corporation
NCT06049680 · Malnutrition, Child, Malnutrition, and more
NCT06905119 · Infusions, Intravenous, Administration, Intravenous, and more
NCT06274788 · Parenteral Nutrition Associated Liver Disease (PNALD), Essential Fatty Acid Deficiency, and more
NCT07392801 · Chronic Intestinal Insufficiency, Advanced Glycation and Products, and more
NCT01072721 · Cirrhosis, Liver Fibrosis, and more
National Cancer Center
Gyeonggi-do, Goyang-si
Chonnam National University Hwasun Hospital
Jeollanam-do, Hwasun-gun
Jeonbuk National University Hospital
Jeollabuk-do, Jeonju-si
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions